These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 6927364)

  • 1. [Experimental methodology for the selection of potential anticancer agents].
    Pérez Mínguez F; Llombart Bosch A
    Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of experimental results in clinical tumor chemotherapy (author's transl)].
    Somfai-Relle S; Sugár J
    Arch Geschwulstforsch; 1980; 50(2):132-40. PubMed ID: 7436697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological properties and antitumor activity of a preparation diiodo-benzo-tepa in experiments].
    Trinus FP; Sologub PY; Protsenko LD; Tarnavskaya MI; Nikolaeva SV; Danilenko VS; Sharykina NI; Kolodyazhny VI; Zaikina RG; Goncharenko GV; Kopel'nik MA; Andrianova SM
    Vopr Onkol; 1979; 25(9):53-8. PubMed ID: 90429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proceedings: Pretherapeutic sensitivity testing for chemotherapy of tumors].
    Volm M; Goerttler K; Mattern J; Wayss K; Kaufmann M
    Verh Dtsch Ges Pathol; 1974; 58():509. PubMed ID: 4460529
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan).
    Giovanella BC; Stehlin JS; Hinz HR; Kozielski AJ; Harris NJ; Vardeman DM
    Int J Oncol; 2002 Jan; 20(1):81-8. PubMed ID: 11743646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXXVI. Plant extracts.
    Abbott BJ; Hartwell JL; Iltis HH; Kupchan SM; Leiter J; Perdue RE; Schepartz SA
    Cancer Res; 1966 Sep; 26(9 Pt 2):1131-271. PubMed ID: 5212555
    [No Abstract]   [Full Text] [Related]  

  • 7. [Introduction of new screening system in National Cancer Institute].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methodical aspects in studies on the carcinogenesis and chemotherapy of tumors].
    Schmähl D
    Planta Med; 1968; ():3-12. PubMed ID: 4976078
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G
    IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICRF-187 in clinical oncology.
    Poster DS; Penta JS; Bruno S; Macdonald JS
    Cancer Clin Trials; 1981; 4(2):143-6. PubMed ID: 6788388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of results of animal experiments in clinical tumor chemotherapy].
    Sugár J; Somfai-Relle Z; Németh L
    Orv Hetil; 1980 Jul; 121(29):1745-52. PubMed ID: 7454286
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicology of anticancer drugs.
    Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):49-55. PubMed ID: 412105
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preclinical studies for development of anti-cancer drugs: current and historical status and problems].
    Okabe M; Kobayashi S; Hirata T; Nakano H; Ikegami J; Inoue K; Komuro T
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():302-9. PubMed ID: 7986108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems specific to chemotherapy of intracerebral tumors].
    Hirsch JF
    Neurochirurgie; 1974; 20(3):233-46. PubMed ID: 4219038
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXXV.
    Schepartz SA; Abbott BJ; Leiter J
    Cancer Res; 1966 Aug; 26(8 Pt 2):950-1113. PubMed ID: 5950748
    [No Abstract]   [Full Text] [Related]  

  • 17. Basic cancer chemotherapy: experimental models--strategy.
    Mulder JH
    Cancer Clin Trials; 1978; 1(2):129-34. PubMed ID: 391424
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XLIV.
    Schepartz SA; Abbott BJ; Leiter J
    Cancer Res; 1967 Oct; 27(10 Suppl):921-1032. PubMed ID: 6077483
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXXII. Plant extracts.
    Abbott BJ; Leiter J; Hartwell JL; Perdue RE; Schepartz SA
    Cancer Res; 1966 Apr; 26(4 Pt 2):391-569. PubMed ID: 5940852
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXXI. Plant extracts.
    Abbott BJ; Leiter J; Hartwell JL; Price JR; Perdue RE; Schepartz SA
    Cancer Res; 1966 Mar; 26(3 Pt 2):207-373. PubMed ID: 5212552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.